Susan Clement Davies
Directeur/Membre du Conseil chez SCANCELL HOLDINGS PLC
Postes actifs de Susan Clement Davies
Sociétés | Poste | Début | Fin |
---|---|---|---|
SCANCELL HOLDINGS PLC | Directeur/Membre du Conseil | 24/09/2020 | - |
SCIENCE GROUP PLC | Directeur/Membre du Conseil | 18/05/2022 | - |
Independent Dir/Board Member | 18/05/2022 | - | |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 01/01/2022 | - |
Independent Dir/Board Member | 01/01/2022 | - | |
Exploristics Ltd. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Susan Clement Davies
Anciens postes connus de Susan Clement Davies
Sociétés | Poste | Début | Fin |
---|---|---|---|
THERACRYF PLC | Directeur/Membre du Conseil | 01/11/2018 | 31/12/2023 |
Independent Dir/Board Member | 01/11/2018 | 31/12/2023 | |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Corporate Officer/Principal | - | 01/01/2018 |
Citigroup Global Markets Ltd.
Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Corporate Officer/Principal | - | 01/01/2018 |
Formation de Susan Clement Davies
London School of Economics & Political Science | Graduate Degree |
University College London | Undergraduate Degree |
Statistiques
Internationale
Royaume-Uni | 9 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 5 |
Independent Dir/Board Member | 3 |
Corporate Officer/Principal | 2 |
Sectorielle
Finance | 3 |
Consumer Services | 3 |
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
THERACRYF PLC | Health Services |
SCIENCE GROUP PLC | Commercial Services |
SCANCELL HOLDINGS PLC | Health Technology |
Entreprise privées | 4 |
---|---|
Citigroup Global Markets Ltd.
Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Finance |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Finance |
Exploristics Ltd. | |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Susan Clement Davies
- Expérience